Xolair (omalizumab) Powder for Injection
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
December 2015
WARNINGS AND PRECAUTIONS
Anaphylaxis
A case-control study showed that, among Xolair users, patients with a history...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts